Jecko Thachil/LinkedIn
Mar 14, 2026, 15:40
Jecko Thachil: Anticoagulation in Patients With Metabolic-Associated Fatty Liver Disease
Jecko Thachil, Consultant Haematologist at NHS, shared a post on LinkedIn about about a recent article he and his colleagues co-authored, adding:
“Patients with liver disease were historically considered to be at increased risk of bleeding. But, now we know that such patients may actually be at increased risk of thrombosis, especially in setting of metabolic associated fatty liver disease or staetohepatitis.
How do we anticoagulate such patients?”
Title: The prothrombotic tendency of metabolic-associated fatty liver disease
Authors: Dawn Swan, Ton Lisman, Armando Tripodi, Jecko Thachil
Read the Full Article on Journal of Thrombosis and Haemostasis
Other posts featuring Jecko Thachil on Hemostasis Today.
-
Aug 14, 2026, 13:43Edward Lee Carter: Optimizing Anticoagulation in Cirrhosis Beyond the Lab Numbers
-
Aug 14, 2026, 13:39Amr Saad: What Tips You Toward Cerebral Venous Thrombosis Over IIH?
-
Aug 14, 2026, 13:28Eduardo Medronha: DIPS as a Rescue Strategy in Budd–Chiari Syndrome
-
Aug 14, 2026, 13:18Immune Checkpoint Inhibitors Have Transformed Cancer Treatment – RPTH Journal
-
Aug 14, 2026, 13:04Mohammed M. Aboudeif: Cerebral Venous Thrombosis – Think Early, Treat Decisively
-
Aug 14, 2026, 12:49Ahmed Hawash: The Hawash Method for Managing Extreme ICU Complexity
-
Aug 14, 2026, 12:42Why Unfractionated Heparin Still Matters in Modern Anticoagulation – Thrombosis Canada
-
Aug 14, 2026, 11:40Liz Devlin: When HHT Affects More Than What We Can See
-
Aug 14, 2026, 11:29Archil Jaliashvili: Can Italy Reduce Its Dependence on Imported Plasma